We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App

Saliva Tests Are as Accurate and Effective as Nasopharyngeal Tests in Precisely Diagnosing COVID-19, Finds Study

By LabMedica International staff writers
Posted on 17 Feb 2021
Print article
Image: Allplex SARS-CoV-2 Assay (Photo courtesy of Seegene, Inc.)
Image: Allplex SARS-CoV-2 Assay (Photo courtesy of Seegene, Inc.)
A new study has shown that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen.

A research team at the Department of Laboratory Medicine at Kangwon National University School of Medicine (Seoul, Korea) carried out the PCR test for COVID-19 on 90 hospitalized individuals with suspected COVID-19, both with saliva and nasopharyngeal methods. In order to collect sufficient specimen, samples were collected from study participants, who were required to refrain from any activities including eating, drinking, and smoking, for 30 minutes after they got up in the morning.

For the study, the research team had used Seegene, Inc.’s (Seoul, Korea) COVID-19 tests, the Allplex SARS-CoV-2 Assay and Allplex SARS-CoV-2/FluA/FluB/RSV Assay. While the Allplex SARS-CoV-2 Assay targets four different genes of COVID-19, the Allplex SARS-CoV-2/FluA/FluB/RSV Assay is known to detect and differentiate eight target genes, including COVID-19, influenza and RSV common cold.

As a result, both the Allplex SARS-CoV-2 Assay and Allplex SARS-CoV-2/FluA/FluB/RSV Assay proved the saliva and nasopharyngeal test's percentage agreement for detecting COVID-19 was over 98.8%. That means COVID-19 diagnostic tests give equally accurate and effective test results for COVID-19 when testing saliva and nasopharyngeal specimen.

The research team also conducted a separate study on extraction-free application, one without the nucleic acid extraction step, and found the percentage agreement between Seegene's extraction-free saliva test and extraction-free nasopharyngeal swab test to be over 96%. In other words, the extraction-free method using the saliva sampling would be just as applicable for the PCR test in detecting SARS-CoV-2.

"The demand for saliva-based COVID-19 tests is on the rise, as the world still battles with short supply of specimen collecting swab for nasopharyngeal tests," said Professor Suh, the lead researcher of the study, adding that the study has "clearly proven that saliva tests are just as accurate and effective as nasopharyngeal tests in precisely diagnosing COVID-19."

Related Links:
Kangwon National University School of Medicine
Seegene, Inc.

Gold Supplier
SARS-CoV-2 (COVID-19) Antibody Test
PrimeStore MTM Kit
Sample Collection Kit
COVID-19 Anitibody Test
Gold Supplier
COVID-19 Test

Print article


Molecular Diagnostics

view channel
Image: Histopathologic image from a patient with Li Fraumeni syndrome showing accumulation of mutant TP53 in tumoral cells (Photo courtesy of Thierry Soussi, PhD).

Clinical Germline Testing Evaluated for Pediatric Cancer Patients

Pediatric cancer is rare, with fewer than 10,000 solid tumors diagnosed in children annually in the USA. Previous studies interrogating germline predisposition broadly across pediatric cancer types have... Read more


view channel

Mindray and Tencent AI Lab to Jointly Develop AI Products for Blood Disease Screening and In Vitro Diagnosis

Shenzhen Mindray Biomedical Electronics Co., Ltd. (Shenzhen, China) has signed an AI cooperation framework agreement with Tencent AI Lab (Shenzhen, China) to jointly develop AI products for blood cell... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.